Theralase Technologies (TSXV:TLT) Short Interest


TSXV:TLT Theralase Technologies Inc TSXV:TLT
39 GF Score
Price C$0.23
GF Value C$0.18
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Theralase Technologies Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

TSXV:TLT vs ABT, SYK, MDT: Short Interest Comparison

For the Medical Devices subindustry, Theralase Technologies's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Theralase Technologies Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Theralase Technologies's Short Interest distribution charts can be found below:

* The bar in red indicates where Theralase Technologies's Short Interest falls into.


TSXV:TLT
39GF Score
Theralase Technologies Inc TSXV:TLT
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Theralase Technologies (TSXV:TLT) Overvalued in 2026?

Based on GuruFocus' analysis, Theralase Technologies stock appears to be overvalued. The current stock price of C$0.23 is trading 27.8% above its estimated GF Value™ of C$0.18. GuruFocus considers Theralase Technologies to be Modestly Overvalued.

Key valuation signals for TSXV:TLT:

  • Short Interest:
  • GF Value™: C$0.18 vs. price of C$0.23 (27.8% above fair value)
  • GF Score™: 39/100 with 4 warning signs

No single metric tells the full story. See the TSXV:TLT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Theralase Technologies Business Description

Other Exchanges TLTFF:USATTX:Germany
Address 41 Hollinger Road, Toronto, ON, CAN, M4B 3G4
Theralase Technologies Inc brings CLT to patients and personalized ACT to patients based on individual tissue characteristics. It is two separate reportable operating divisions; the Drug Division and the Device Division. The Drug Division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs), and activates them with proprietary and patent-pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The Device Division designs develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the Food and Drug Administration (FDA) for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions.
39GF Score

Get the complete analysis for TSXV:TLT

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.23
Price
C$0.18
GF Value